Rapid Dose Provides Update on Common Share Private Placement

Burlington, Ontario--(Newsfile Corp. - June 19, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that further to its press release dated May 8, 2024, regardin

newsfileJun 19 19:54

Rapid Dose Therapeutics Commits to NFL-Funded Clinical Trial Application

Burlington, Ontario--(Newsfile Corp. - May 29, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announces its collaboration in the National Football League (NFL) – funded cli

newsfileMay 29 22:40

CSE Bulletin: Reinstatement - Rapid Dose Therapeutics Corp. (DOSE)

Toronto, Ontario--(Newsfile Corp. - Le 4 mai/May 2023) - Effective immediately, Rapid Dose Therapeutics Corp. will be reinstated for trading. The Company has rectified the situation that gave rise to

newsfileMay 4, 2023 23:10

CSE Bulletin: Suspension - Rapid Dose Therapeutics Corp. (DOSE)

Toronto, Ontario--(Newsfile Corp. - Le 29 août/August 2022) - Effective immediately, Rapid Dose Therapeutics Corp. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt

newsfileAug 30, 2022 00:55